Literature DB >> 6151870

Anticipatory nausea and/or vomiting.

D Moher, A Z Arthur, J L Pater.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6151870     DOI： 10.1016/0305-7372(84)90011-2

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  9 in total

1.  Antiemetic study design: desirable objectives, stratifications and analyses.

Authors:  I N Olver
Journal:  Br J Cancer Suppl       Date:  1992-12

Review 2.  Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles.

Authors:  Juan Bayo; Paula J Fonseca; Susana Hernando; S Servitja; A Calvo; S Falagan; Estefanía García; Iria González; María José de Miguel; Quionia Pérez; Ana Milena; Antonio Ruiz; Agustí Barnadas
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

3.  Chemotherapy-induced nausea and vomiting #285.

Authors:  Nishant Tageja; Hunter Groninger
Journal:  J Palliat Med       Date:  2014-12       Impact factor: 2.947

Review 4.  Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.

Authors:  Michelle C Janelsins; Mohamedtaki A Tejani; Charles Kamen; Anita R Peoples; Karen M Mustian; Gary R Morrow
Journal:  Expert Opin Pharmacother       Date:  2013-04       Impact factor: 3.889

5.  Treatment of Nausea and Vomiting During Chemotherapy.

Authors:  Karen M Mustian; Katie Devine; Julie L Ryan; Michelle C Janelsins; Lisa K Sprod; Luke J Peppone; Grace D Candelario; Supriya G Mohile; Gary R Morrow
Journal:  US Oncol Hematol       Date:  2011

6.  A randomized controlled study evaluating the efficacy of aprepitant for highly/moderately emetogenic chemotherapies in hematological malignancies.

Authors:  R Nasu; Y Nannya; M Kurokawa
Journal:  Int J Hematol       Date:  2015-02-03       Impact factor: 2.490

Review 7.  Chemotherapy-induced nausea and vomiting: optimizing prevention and management.

Authors:  Kamakshi V Rao; Aimee Faso
Journal:  Am Health Drug Benefits       Date:  2012-07

Review 8.  Chemotherapy induced emesis--mechanisms and treatment: a review.

Authors:  C M Edwards
Journal:  J R Soc Med       Date:  1988-11       Impact factor: 18.000

9.  The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India.

Authors:  Govind Babu; Smitha Carol Saldanha; Lakshmaiah Kuntegowdanahalli Chinnagiriyappa; Linu Abraham Jacob; Suresh Babu Mallekavu; Loknatha Dasappa; Pretesh Rohan Kiran; Aparna Sreevatsa; Sandhya Appachu; Vineetha Unnikrishnan; Venugopal Arroju
Journal:  Chemother Res Pract       Date:  2016-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.